A Community-based Participatory Intervention to Change Attitudes Towards Female Circumcision Among Somali Immigrants in Sweden

Overview

Female circumcision (FC) causes both immediate and long-term health consequences. In general, the more severe type of FC, the worse health consequences can be seen. Despite the negative health effects, the practice of FC is still found to be highly prevalent in many countries, mainly in Africa and the Middle East. Many studies have been performed on FC in African countries where the custom is widespread and there have also been many attempts to eradicate the practice in these countries. However, considerably less research exists on FC in non-practicing societies where there has been an influx of immigrants from countries that traditionally carry out this practice. Further, no anti-FC interventions designed using a comparison group have been performed in any country outside Africa. This cluster randomized controlled trial aims to evaluate the effectiveness of a community-based participatory intervention on changing attitudes towards FC among newly arrived Somali immigrants in Sweden. Included in the research is an assessment of the acceptability of the intervention. Based on social convention theory, we hypothesize that an interaction between established Somali immigrants, thought to be predominantly opponents of FC, and newly arrived Somali immigrants will facilitate changes in attitudes among the newly arrived. The trial will be implemented in two municipalities in Sweden that have a high proportion of Somali immigrants. Somali organizations in these municipalities will constitute the clusters. In total, 8 clusters will be included, 4 intervention clusters and 4 control clusters.

Full Title of Study: “A Community-based Participatory Intervention to Change Attitudes Towards Female Circumcision Among Somali Immigrants in Sweden: a Cluster Randomized Controlled Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: March 2016

Interventions

  • Behavioral: Attitude change towards female circumcision
    • The intervention comprises of a series of meetings between newly arrived Somalis and established Somalis. At each meeting, a pre-determined topic relating to FC will be discussed. The topics include culture, religion, health, children’s rights, and Swedish laws. Different experts, chosen to match the specific topic of the meeting will be invited to each meeting to facilitate the interactive discussions between the participants. Somalis who are both familiar with the Swedish and Somali culture will facilitate the meetings. The intervention spans over a time period of six months. The intervention meetings will be held during the first five months of the intervention period; one meeting scheduled per month. Thereafter, there will be a ‘wash-out’ period of one month to allow for reflections and to minimize the risk of courtesy bias.
  • Other: No intervention

Arms, Groups and Cohorts

  • Other: Intervention
    • Attitude change towards female circumcision
  • Other: No intervention
    • No intervention

Clinical Trial Outcome Measures

Primary Measures

  • Visual Analogue Scale (VAS) of types of female circumcision (change in what type of female circumcision the participant thinks is acceptable to do)
    • Time Frame: The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
    • In the VAS, 0 mm indicates that no type of female circumcision is regarded as acceptable to do, and 100 mm indicates that all types of female circumcision are regarded as acceptable to do. The outcome will be the change in what type of female circumcision the participant thinks is acceptable to do, as measured by the change from the pre-intervention score.
  • Visual Analogue Scale (VAS) of types of female circumcision (change in what type of female circumcision the participant would perform if he/she had a daughter, as measured by the change from the pre-intervention score)
    • Time Frame: The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
    • In the VAS, 0 mm indicates that the participant would not perform any type of female circumcision on his/her hypothesized daughter, and 100 mm indicates that the participant would perform the most extensive type of female circumcision on his/her hypothesized daughter. The outcome will be the change in what type of female circumcision the participant would perform if he/she had a daughter, as measured by the change from the pre-intervention score.
  • The change in proportion of participants who oppose the continuation of female circumcision
    • Time Frame: The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention

Secondary Measures

  • Visual Analogue Scale (VAS) of types of female circumcision (participant assesses that Somali men in Sweden think that performing any type of female circumcision is not acceptable or acceptable)
    • Time Frame: The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
    • In the VAS, 0 mm indicates that the participant assesses that Somali men in Sweden think that performing any type of female circumcision is not acceptable, and 100 mm indicates that the participant assesses that Somali men in Sweden think performing any type of female circumcision is acceptable. The outcome will be the change in the participant’s assessment, as measured by the change from the pre-intervention score.
  • Visual Analogue Scale (VAS) of types of female circumcision (participant assesses that Somali women in Sweden think performing any type of female circumcision is acceptable or not acceptable)
    • Time Frame: The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
    • In the VAS, 0 mm indicates that the participant assesses that Somali women in Sweden think performing any type of female circumcision is acceptable, and 100 mm indicates that the participant assesses that Somali women in Sweden think that performing all types of female circumcision is acceptable. The outcome will be the change in the participant’s assessment, as measured by the change from the pre-intervention score.
  • Visual Analogue Scale (VAS) of number of individuals performing female circumcision
    • Time Frame: The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
    • In the VAS, 0 mm indicates that the participant assesses that no one within the Somali community in Sweden circumcise their daughters, and 100 mm indicates that the participant assesses that everybody within the Somali community in Sweden circumcise their daughters. The outcome will be the change in the participant’s assessment, as measured by the change from the pre-intervention score.
  • Change in answers to questions specifically related to one of the five topics of the intervention meetings
    • Time Frame: The outcome measures will be assessed before the intervention and approximately 1-30 days after the intervention.
  • Outcomes will be analyzed for associations with number of attended intervention meetings.
    • Time Frame: The outcome measure will be assessed approximately 1-30 days after the intervention.
  • Acceptability (questionnaire will be used to collect information about acceptability of the intervention)
    • Time Frame: The outcome measure will be assessed approximately 1-30 days after the intervention.
    • A questionnaire will be used to collect information about acceptability of the intervention.

Participating in This Clinical Trial

Inclusion Criteria

  • Oral informed consent – Newly arrived (lived in Sweden for ≤ 4 years) Somali immigrants in Sweden with a residence permit – Men and women, ≥ 18 years old Exclusion Criteria:

  • None

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Uppsala University
  • Collaborator
    • Malmö University
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Birgitta Essén, MD, PhD, Principal Investigator, Uppsala University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.